Plicit Capital Corp Stock Toronto S.E.
Equities
PLPh
CA7291431079
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
May. 15 | Telo Genomics Corp. Signs Collaboration Agreement with Emery Pharma | CI |
Apr. 10 | Telo Genomics Receives Accreditation from College of American Pathologists | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 20.99M 0 |
---|---|---|---|---|---|
Net income 2022 | -2M - | Net income 2023 | -2M - | EV / Sales 2022 | - |
Net cash position 2022 | 2.65M 0 | Net cash position 2023 | 2.64M 0 | EV / Sales 2023 | - |
P/E ratio 2022 |
-9.95
x | P/E ratio 2023 |
-6.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.01% |
Managers | Title | Age | Since |
---|---|---|---|
Kris Weinberg
CEO | Chief Executive Officer | - | 22-12-11 |
Sherif Louis
PSD | President | - | 14-12-31 |
Christopher Ross
DFI | Director of Finance/CFO | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Meekison
BRD | Director/Board Member | 58 | 18-06-30 |
Director/Board Member | - | 22-02-02 | |
Guido Baechler
CHM | Chairman | 59 | 19-02-27 |
1st Jan change | Capi. | |
---|---|---|
-31.90% | 9.3B | |
-6.25% | 3.1B | |
-13.96% | 2.17B | |
-16.83% | 1.75B | |
+72.82% | 1.5B | |
+29.17% | 807M | |
-2.62% | 759M | |
-26.33% | 532M | |
+4.97% | 313M |
- Stock Market
- Equities
- TELO Stock
- PLPh Stock